Ricky Cain

发表

Design and synthesis of metallo-β-lactamase inhibitors

Ricky Cain, 2015 .

Anti-biofilm efficacy of a medieval treatment for bacterial infection requires the combination of multiple ingredients

D. Barrett, F. Harrison, C. Corre, 2020, Scientific Reports.

Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates.

Samuel T. Cahill, C. Fishwick, C. Schofield, 2019, Biochimica et biophysica acta. General subjects.

Structure-guided enhancement of selectivity of chemical probe inhibitors targeting bacterial seryl-tRNA synthetase

C. Fishwick, L. Czaplewski, D. Scott, 2019, bioRxiv.

Structural and mechanistic studies reveal the effectiveness of non-classical (cid:533) -lactamase 1 inhibitors against extensively drug resistant Stenotrophomonas maltophilia.

Samar, C. Fishwick, K. Heesom, 2018 .

Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates

Samuel T. Cahill, C. Fishwick, C. Schofield, 2016, Nature Communications.

Profiling interactions of vaborbactam with metallo-β-lactamases

C. Schofield, C. Dowson, J. Brem, 2019, Bioorganic & medicinal chemistry letters.

Structure-guided enhancement of selectivity of chemical probe inhibitors targeting bacterial seryl-tRNA synthetase.

C. Fishwick, L. Czaplewski, D. Scott, 2019, Journal of medicinal chemistry.

Anti-biofilm efficacy of a medieval treatment for bacterial infection requires the combination of multiple ingredients

D. Barrett, F. Harrison, C. Corre, 2020, Scientific Reports.

Assay Platform for Clinically Relevant Metallo-β-lactamases

R. Owens, C. Fishwick, C. Schofield, 2013, Journal of medicinal chemistry.

Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli

C. Fishwick, M. Page, C. Schofield, 2020, Biomolecules.

Cyclic Boronates Inhibit All Classes of β-Lactamases

Samuel T. Cahill, C. Fishwick, C. Schofield, 2017, Antimicrobial Agents and Chemotherapy.

Cyclic Boronates Inhibit All Classes of -Lactamases. Antimicrobial

Samuel T. Cahill, C. Fishwick, C. Schofield, 2016 .

Structural/mechanistic insights into the efficacy of nonclassical β‐lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates

C. Fishwick, C. Schofield, K. Heesom, 2017, Molecular microbiology.

A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatment.

C. Fishwick, A. Clark, P. Taylor, 2017, Cancer letters.

Discovery of Novel UDP-N-Acetylglucosamine Acyltransferase (LpxA) Inhibitors with Activity against Pseudomonas aeruginosa.

Anthony D. Keefe, Christoph E. Dumelin, A. Keefe, 2021, Journal of medicinal chemistry.

Computational Methods to Identify New Antibacterial Targets

C. Fishwick, K. Simmons, M. McPhillie, 2015, Chemical biology & drug design.

In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.

Samuel T. Cahill, C. Fishwick, P. McHugh, 2018, Journal of medicinal chemistry.

A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatment.

C. Fishwick, A. Clark, P. Taylor, 2017, Cancer letters.